In the last three months, 5 analysts have published ratings on Moderna (NASDAQ:MRNA), offering a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 3 | 1 | 1 | 0 |
Last 30D | 0 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 1 | 1 | 1 | 0 |
3M Ago | 0 | 2 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $113.8, a high estimate of $142.00, and a low estimate of $86.00. Observing a 44.97% increase, the current average has risen from the previous average price target of $78.50.
Understanding Analyst Ratings: A...
Login or create a forever free account to read this news
Sign up/Log in